Genetic polymorphism at exon 4 of cytochrome p450 CYP2C9 in Chinese patients might determine the warfarin dose requirement.

被引：0
|
作者：
Leung, AYH
Chow, HCH
Kwong, YL
Lie, AKW
Fung, ATK
Chow, WH
Yip, ASB
Liang, R
机构：
[1] Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Grantham Hosp, Cardiac Med Unit, Hong Kong, Hong Kong, Peoples R China
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2775
引用
收藏
页码：646A / +
页数：2
相关论文
共 50 条
  • [1] Relationship of polymorphisms in the cytochrome P450 CYP2C9 to warfarin dose requirement
    Aithal, GP
    Day, CP
    Tekes, S
    Cox, J
    Kamali, F
    Kesteven, PJL
    Daly, AK
    HEPATOLOGY, 1997, 26 (04) : 1018 - 1018
  • [2] Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
    Aithal, GP
    Day, CP
    Kesteven, PJL
    Daly, AK
    LANCET, 1999, 353 (9154): : 717 - 719
  • [3] Genetic polymorphism in exon 4 of cytochrome P450CYP2C9 may be associated with warfarin sensitivity in Chinese patients
    Leung, AYH
    Chow, HCH
    Kwong, YL
    Lie, AKW
    Fung, ATK
    Chow, WH
    Yip, ASB
    Liang, R
    BLOOD, 2001, 98 (08) : 2584 - 2587
  • [4] Warfarin and celecoxib interaction in the setting of cytochrome P450 (CYP2C9) polymorphism with bleeding complication
    Malhi, H
    Atac, B
    Daly, AK
    Gupta, S
    POSTGRADUATE MEDICAL JOURNAL, 2004, 80 (940) : 107 - 109
  • [5] Analysis of P450CYP2C9 polymorphisms in Italian patients with low warfarin dose requirement.
    Patrosso, CM
    Lando, G
    Figini, A
    Mostarda, G
    Caimi, M
    Baudo, F
    Marocchi, A
    CLINICAL CHEMISTRY, 2000, 46 (06) : A134 - A134
  • [6] Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients:: genetic analysis of the CYP2C9 locus
    Imai, J
    Ieiri, I
    Mamiya, K
    Miyahara, S
    Furuumi, H
    Nanba, E
    Yamane, M
    Fukumaki, Y
    Ninomiya, H
    Tashiro, N
    Otsubo, K
    Higuchi, S
    PHARMACOGENETICS, 2000, 10 (01): : 85 - 89
  • [7] Genetic analysis of the human cytochrome P450 CYP2C9 locus
    Stubbins, MJ
    Harries, LW
    Smith, G
    Tarbit, MH
    Wolf, CR
    PHARMACOGENETICS, 1996, 6 (05): : 429 - 439
  • [8] The effect of genetic polymorphism of cytochrome P450CYP2C9 on phenytoin dose requirement
    van der Weide, J
    Steijns, LSW
    van Weelden, MJM
    de Haan, K
    PHARMACOGENETICS, 2001, 11 (04): : 287 - 291
  • [9] Studies on cytochrome P450CYP2C9 genetic polymorphism in Chinese patients receiving warfarin.
    Leung, AYH
    Liang, RHS
    BLOOD, 1999, 94 (10) : 108B - 108B
  • [10] Effect of CYP2C9 and VKORC1 genetic polymorphism on Warfarin dose requirement
    Ashavaid, T. F.
    Ponde, C. K.
    Raghavan, R.
    Kapadia, F. N.
    Shah, S. A.
    Natarajan, S.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 507 - 508
12345